Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PSY 246 > Midterm 2 (tox) > Flashcards

Midterm 2 (tox) Flashcards

1
Q

what is the regulatory agency for Vet pharmaceuticals

A

veterinary drugs directorate (VDD), health canada
- is covered under the food and drugs act legislature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Extralabel drug use is the use of a drug that is unapproved or not approved to be used in that specific manner. is this more or less common in animals

A

more common - may be used due to a lack of effective or approved products or economic considerationa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what must you consider when doing ELDU in animals

A

the development of antimicrobial resistance, drug residues in food for human consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

category one vs category two antimicrobials

A

category one is very high importance, the preferred treatment option for serious human infections which have no or limited alternative treatment options

category two is high importance, the preferred treatment for serious human infections but there are alternatives that can be used

category one should not be used for ELDU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

maximum residue limits (MRLs)

A

the max level of a residue that could remain in the tissue or food product of a food-producing animal that has been treated with a veterinary drug, with no adverse health effects expected if a human were to ingest this daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what types of drugs used in animals are not routinely monitored for MRLs

A

those with low toxicity, those that are poorly absorbed or have low bioavailability, those that are rapidly metabolized or excreted, those which are infrequently used (used once or twice in an animals lifespan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how are maximum residue limits determined

A

first you have to identify the residue of interest, is it the original chemical or one of its metabolites?

do metabolism studies in the food-producing animal to determine its half life and that of its metabolites

do carcinogenicity and toxicity studies to determine the ADI

do withdrawal periods to get insight into how the residue is depleted in the animal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does the vet pharmacovigilance program do

A

monitors:
- safety and efficacy of vet drugs
- safety of humans handling these drugs
- safety of consuming food products from treated animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

excipients

A

ingredients with no real pharmacological effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

label requirements for NHP

A

product name and license number
quantity of product in the bottle
full list of medicinal and non-medicinal ingredients
recommended use (purpose or health claim)
warnings of possible adverse reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

can NHP bypass clinical trials

A

NHP can bypass clinical trials if there is an abundance of published studies, articles, or traditional resources already describing the therapeutic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

who is responsible for the monitoring of adverse effects of NHP

A

product license holders are responsible for adverse event monitoring and must report them to health Canada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

regulatory agency for cosmetics

A

Healthy environments and consumer safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

regulatory agency for NHP

A

natural and non-prescription health products directorate, Health Canada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F if a cosmetic has no prohibited or restricted ingredients, it does not need to provide testing data to health Canada before first sale

A

true - if it has no prohibited or restricted ingredients the manufacturer only needs to inform health Canada within 10 days of first sale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

products which fall in the cosmetic-drug interface can be regulated by …

A

cosmetic regulations, food and drug regulations, as well as NHP regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

three ways to distinguish between a cosmetic and a drug

A
  1. proposed claim - claims of treatment, diagnosis, prevention, or restoration are often drugs
  2. composition - ingredients or concentrations may classify a product as a drug (corticosteroids)
  3. level of action - if something only acts superficially (no systemic absorption it is likely cosmetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

medical device

A

something that intends to affect the structure or functioning of the body without chemical action or dependence on metabolism - these often require additional non-clinical lab studies like biocompatibility, stress wear, shelf life, microbiology and immunological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

regulatory agency for medical devices

A

Medical Devices Directorate (MDD - Health Canada)
- provides information for Canadians to make informed decisions, does investigational testing authorizations to make sure that studies are well designed and safe for participants, responsible for assessing safety, efficacy and post-market surveillance

  • makes exceptions for medical devices in extenuating circumstances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

classification of diagnostic medical devices

A

1 - general in-vitro lab equipment and reagents (ex - bacterial growth media)
2 - low public health risk - used to detect infectious agents which are not known to be easily propagated
3 - moderate public health risk or high individual risk - where an erroneous result may result in an imminent life-threatening situation ( ex - a missed diagnosis for meningitis or cancer)
4 - high public health risk - failed blood donor screening (HIV diagnosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

classification of non diagnostic medical devices

A

invasive - contacts the surface of the eye or penetrates the body - surgical gloves, dental cement

non-invasive - contacts injured skin - gauze bandages

active devices - require an energy source - CT or X ray machine, electric tooth brush, hearing aid

special rules - disinfection or sterilization devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

novel food agency

A

health products and food branch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

novel foods

A

products which have never been used as food, result from a process which has not previously been used for food, or have been manipulated by GMOs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

genetically modified crops which may pose an environmental risk are regulated by

A

the canada food inspection agency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

when is a notice of proposal administred regarding to food additives

A

Health canada will administer a notice of proposal to the public if a new additive is being considered for approval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

T/F manufacturers must now list colour additives by their specific common name

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hazard

A

the inherent ability of a substance to cause an adverse effect under defined conditions of exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

risk

A

the product of the likelihood of an event and the consequences of an event
- numerical value 0-1
- exposure x effect/hazard = risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

factors which impact risk perception

A

perceived control
previous experiences
bounded rationality (you make assumptions based on the limited information you have and assume it is good enough)
family concerns
analytical ways of thinking (are you more concerned with numbers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

elements of risk assesment

A

hazard identification
risk analysis and evaluation
risk control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

hazard identification

A

consider what is known about the hazard (mechanism of action) and how confident you are in what you know (quality and quantity of data)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

exposure assesment

A

identifying key populations (usually children and the elderly), routes of exposure, degree of exposure, where the most significant sources of exposure are if there are multiple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

retrospective risk assessment is more common when assessing

A

pesticides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

effect assesment

A

defining the threshold of exposure above which the tested substance will cause adverse effects - done using animal models most often

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

equation for defining the Reference dosei

A

NOAEL x uncertainty factors x modifying factors

35
Q

what are uncertainty factors

A

multiples of ten which speak to the degree of uncertainty about the results of a study/risk assesment - for example if you have to extrapolate data from a long term animal study due to a lack of human data you add an UF so your NOAEL is multiplied by 10

36
Q

how is risk characertization done for noncarcinogens

A

Hazard quotient = MDD / RfD

if the HQ is equal or less than 0.2 it is negligible

if the HQ is equal to or less than 1, we say there are no adverse effects expected

1-10 = some potential risks are expected and you should reassess

over 10 there are increased potential health risks and you should implement risk management measures

37
Q

how is risk characertization done for Carcinogens

A

LADD (lifetime average daily dose) x SF (cancer slope factor)

10 ^-6 is acceptable or insignificant
10^-6 - 10^-4 is potentially risky
10^-4 and up is significant

when there is exposure to more than one risk you combine them additively

38
Q

major sources of uncertainty

A

the studies were only observational
you had to extrapolate data from animals to humans or from high dose exposures to low dose exposures
interindividual variability

39
Q

what is the timeline of CEPA 1999

A

replaced CEPA 1988, amendments made in 2018, more amendments made in 2023

40
Q

what is CEPA 1999’s main goal

A

contribute to sustainable development

41
Q

what does CEPA stand for

A

Canadian Environmental Protection Act

42
Q

what were the calls for revisions to CEPA in 2017

A

better protect vulnerable populations
focus on high concern chemicals
updates concerning air quality

43
Q

amendments to cepa introduced in 2021/passed in 2023

A

every canadian has the right to a healthy environment, fracking and tailings are areas of concern

44
Q

9 principles of CEPA

A
  1. sustainable development
  2. pollution prevention
  3. virtual elimination (of persistant bioaccumulative toxins)
  4. ecosystem approach (opposed to political borders)
  5. precautionary principle
  6. intergovernmental cooperation
  7. national standards
  8. polluter pays principle
  9. science based decision making
45
Q

what is the definition of a CEPA toxin

A
  1. immediate or long term harmful effect on the environment and biodiversity
  2. danger to the environment on which life depends
  3. danger to human life or health
46
Q

CCMP

A

canada’s chemical management plan - introduced 2006 - perform risk assessments on chemicals introduced prior to 1994 and categorize them as harmful or not and implement risk management measures

47
Q

timing of the phases of CCMP

A

2006 initiation
2011 a whole bunch of more chemicals added
2016 - now is ongoing

48
Q

malluscicides

A

kills snails and slugs

49
Q

acaricides

A

kills mites

50
Q

of the total land area of crops in canada ____ percent are treated with herbicides

A

84%

51
Q

examples of intentional pesticide exposure

A

public hygeine, vector control, human and veterinary medicine

52
Q

PMRA

A

pest management regulatory agency
- the federal agency for the regulation of pesticides in canada

53
Q

what act does the pest management regulatory agency work under/ enforce

A

pest control products act (PCPA)

54
Q

primary mandate of the PMRA

A

prevent unacceptable risks to humans and to the environment

55
Q

secondary mandates of the PMRA

A

support sustainable development in agriculture
encourage the use of lower risk products and strategies for pest management
minimize health and environmental risks
increase public awareness of regulatory process

56
Q

during the pesticide registration process, the PMRA will review

A

risk to humans, environment and the effictiveness of the productt

57
Q

timeframe of the pesticide registration process

A

initial product chemistry and efficacy screening - 4-5 years
researching toxicology - 3-4 years
regulatory evaluation - 1-2 years

58
Q

PCPA

A

pest control products act - federal law controlling the import, sale, manufacture, and use of pesticides in Canada - reformed in 2002

59
Q

the PCPA was reformed in 2002 with these new objectives being added

A
  1. strengthen environmental and human protection - safety factors for vulnerable groups, aggregating exposures, encouraging the registration of only low risk and USEFUL pesticides
  2. make the registration system more transparent - allow public consults, make givernemnts share and make agencies show PMRA their data
  3. strengthen post registration control - required incident reporting, re-eval old pesticides every 15 years, precautionary principle
60
Q

6 categories of incidents involving pesticides

A

humans, domestic animal, environment (lawn damage), food residues, packaging failure, scientific study

domestic animal is most common, then human, then environment

61
Q

what are the four (five) divisions of the pest management regulatory agency

A

pre-review screening: make sure submission are in the right format and have paid the fees

human health

environment assessment

laboratory services - evaluate product chem data - is the product what it says it should be

value and efficacy assessments - does the product do what it says it should when used according to the label and is this meaningful enough to warrant it’s approval

62
Q

human health division of PMRA consists of

A

tox evaluations - determines the ADI - how bad is the product

occupational exposure assessment - determine the margins of exposure (MOEs) - how much pesticide exposure can occur in a given day

food residue exposure assesment - how much pesticide exposure through our food and drink - set the MRL (maximum residue limit)

63
Q

margin of exposure (MOEs)

A

NOAEL / Predicted dose

64
Q

two components of the environmental assessment branch of the PMRA

A

chemistry and fate - what happens to the pesticide - make recommendations to limit risk

toxicology - how toxic is the pesticide to all non-human organisms - determine the NOEC - no observed effect concentrations

65
Q

what is the end point for acute studies of pesticide toxicity

A

determine lethality dose

66
Q

what are the goals for short term toxicity studies

A

determine the effects of repeated exposure over a short period of time - determine its mechanism and target organs - determine dose for long term studies

67
Q

goal of long term study

A

fine the NOAEL

68
Q

which type of human health acute studies are required for pesticides

A

oral, dermal, inhalation, primary irritation (eye and dermal), dermal sensitization

69
Q

environmental fate studies base their conclusions on the following four types of data

A

physical and chemical properties of the pesticide (water solubility, Kow)

transformation process - what might the pesticide transform into as it is degraded (under environmental conditions like the sun)

mobility studies - done in lab - can ground use pesticides move through soils and end up in water

field studies - required in Canada - substantiate lab mobility studies and learn more about persistence and mobility

70
Q

TGAI

A

technical grade active ingredient

71
Q

EP

A

end-use product

72
Q

acute studies focus on both _____ in examining pesticides for human health

A

technical grade active ingredient and end-use product

73
Q

short term pesticide studies requried:

A

rodents (oral and dermal) and non rodents (oral)- TGAI -

74
Q

required longterm studies for pesticides

A

find NOAEL - rodents - oral - TGAI - chronic and oncogenicity

75
Q

required special studies for pesticides and human health

A

should do oral studies on the TGAI for multigenerational reproductive and development, teratogenicity, metabolism and toxicokinetics

76
Q

required terrestrial invertebrate study

A

only earth worm acute toxicity, but pollinator studies are more common too because of their importance

77
Q

required aquatic studies

A

daphnia - acute and chronic (freshwater invertebrate)

no marine studies required across Canada

acute studies for both cold and warm water fish

78
Q

wild bird required studies

A

dietary acute oral quail and duck

79
Q

required plant studies

A

freshwater algae, terrestrial and aquatic vascular plants

80
Q

which type of studies can determine NOEAL

A

chronic and special studies

81
Q

two main safety factor (extrapolations) for pesticide human risk assesment

A
  • extrapolate from animals to human (interspecies variation)
  • variation within human population

results in reference dose = NOAEL / 100 (ten x ten)

82
Q

how do we determine if a reference dose is reasonable?

A

the reference dose (acceptable daily intake) cannot be lower than the estimated daily exposure (you cannot be estimated to be exposed to more of a chemical than is considered acceptable - reference dose)

83
Q

difference between ADI and acceptable reference dose

A

ADI is the amount of a pesticide that is considered safe for humans to consume each day for an entire lifetime

ARfD is the dose which a person could be exposed to on any given day and expect no adverse health effects

84
Q

cancer risk assessment for pesticides

A

estimates the probability of cancer being caused by an average daily life time exposure - lifetime risk of less than one in a million is considered acceptable for the general population through exposure to pesticide residues

85
Q

quantitative risk assessment for environment

A

ratio the highest no observed effect conc (NOEC) to the expected environmental conc (EEC) of the most sensitive species in that relevant area

if the ratio is larger than one, there is a sufficiently large margin of safety and no risk

PSY 246 (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions